Cargando…

Specific deactivation of monocyte and lymphocyte migration by antithrombin III

Detalles Bibliográficos
Autores principales:	Reinisch, C, Kaneider, N, Rabensteiner, A, Dunzendorfer, S, Römisch, J, Wiedermann, CJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333290/ http://dx.doi.org/10.1186/cc1170

Ejemplares similares

Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000)

G-protein- and phosphodiesterase-dependent regulation of neutrophil migration by antithrombin III involving CXC-receptor 1
por: Dunzendorfer, S, et al.
Publicado: (2000)

Syndecan-4 on human peripheral blood lymphocytes and monocytes mediates effects of antithrombin on chemotaxis
por: Kaneider, NC, et al.
Publicado: (2002)

Distinct antithrombin III preparations deactivate IL-8-induced neutrophil chemotaxis with different potency
por: Kaneider, N, et al.
Publicado: (2001)

Inhibition of proliferation and induction of differentiation of endothelial cells by antithrombin
por: Reinisch, CM, et al.
Publicado: (2002)

Lipopolysaccharides-induced interleukin-8 production is inhibited by antithrombin
por: Gray, E, et al.
Publicado: (2001)

Lipopolysaccharide induced procoagulant activity and cytokine production: influence of antithrombin
por: Gray, E, et al.
Publicado: (2000)

Effect of antithrombin III (AT) on lipopolysaccharide (LPS)-induced production of tissue factor and interleukin-6 (IL-6) by human umbilical vein endothelial cells (HUVECs), mononuclear cells (MNCs) and whole blood
por: Souter, PJ, et al.
Publicado: (1999)

Decreased Protein C, Protein S and Antithrombin III Levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei
por: Larosa, SP, et al.
Publicado: (2000)

Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin III
por: Hoffmann, JN, et al.
Publicado: (1999)

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis
por: Inthorn, D, et al.
Publicado: (1998)

Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998)

Antithrombin III (AT III) prevents increased permeability and leukocyte adhesion in response to endotoxin (LPS) in the microcirculation of rat mesentery
por: Leithäuser, B, et al.
Publicado: (1999)

Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001)

Effects of Antithrombin III on body cavity effusions, fluid balance, colloid osmotic pressure and hemodynamics in porcine septic shock
por: Cobas Meyer, M, et al.
Publicado: (2000)

Antithrombin (AT) improves inflammation induced microcirculatory disturbance in rat mesentery
por: Leithäuser, B, et al.
Publicado: (2000)

Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report
por: Giarratano, A, et al.
Publicado: (2000)

Antithrombin prevents proinflammatory activation via NFκ and MAPK signaling pathways
por: Oelschläger, C, et al.
Publicado: (2002)

Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Marked reductions of protein C and antithrombin in post-trauma DIC have close relations with MODS and poor outcome
por: Gando, S, et al.
Publicado: (2002)

Direct antimicrobial activity of antithrombin?
por: Wiedermann, Christian J, et al.
Publicado: (2010)

Enhanced transendothelial in vitro migration of scleroderma lymphocytes
por: Stummvoll, GH, et al.
Publicado: (2001)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

Monocyte-specific gene signatures in rheumatoid arthritis
por: Grützkau, A, et al.
Publicado: (2004)

Antithrombin reduces the ischemia/reperfusion-induced hepatic injury by increasing hepatic levels of prostacyclin through activation of capsaicin-sensitive sensory neurons in rats
por: Harada, N, et al.
Publicado: (2002)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

Voriconazole and target-site penetration into human tissue
por: Weiler, Stefan, et al.
Publicado: (2008)

Amphotericin B lipid formulations and target-site penetration into human body fluids
por: Weiler, Stefan, et al.
Publicado: (2008)

Antithrombin substitution before extracorporeal circulation attenuates perioperative coagulation activation and might decrease postoperative troponin elevation: a report of preliminary data
por: Busley, R, et al.
Publicado: (2003)

Clinical review: Molecular mechanisms underlying the role of antithrombin in sepsis
por: Wiedermann, Christian J
Publicado: (2006)

Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9
por: Kaneider, Nicole C, et al.
Publicado: (2010)

Inhibition of HCV by the serpin antithrombin III
por: Asmal, Mohammed, et al.
Publicado: (2012)

Proper diagnosis of antithrombin III deficiency
por: Özdemir, Zehra Narlı, et al.
Publicado: (2017)

Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma
por: Koudriavtseva, Tatiana, et al.
Publicado: (2021)

Increased FcγRII and III expression in synovium and on monocyte derived macrophages of RA-patients results in altered function after immune complex stimulation
por: Blom, AB, et al.
Publicado: (2002)

Stromal cell derived factor-1 (CXCL12) induces cell migration into lymph nodes transplanted into SCID MICE. An investigation of lymphocyte migration to secondary lymphoid organs
por: Blades, MC, et al.
Publicado: (2002)

Procalcitonin is released by human monocytes
por: Russwurm, S, et al.
Publicado: (1999)

Deficiency Of Antithrombin III (AT III) - Case Report and Review of the Literature
por: GĂMAN, AMELIA MARIA, et al.
Publicado: (2014)

Artificial colloids influence survival rate of human monocytes
por: Deschner, N, et al.
Publicado: (1999)

Monocytes and Macrophages in Synovitis: Villains or Victims?
por: Burmester, Gerd R, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_q47p8s2ab1uem17djpr455lppi